Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

APUS

Apimeds Pharmaceuticals US, Inc.

CIK 0001894525 · NYSE American

NYSE AmericanHealth CarePharmaceutical Preparations
$4.84
↑ 0.45 (10.25%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$7.30M
P/E Ratio
-0.13
EPS
-0.55
Dividend Yield
Not covered
52W Position
55%
Beta
1.23

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.07
P/S
Not covered
EV/Revenue
Not covered
ROE
-54.6%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 55%
$0.61$8.28

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$6.00M
Total Assets
$164.18M
Free Cash Flow
-$8.98M

Recent news